When Pfizer (NYSE: PFE) reported its fourth-quarter 2016 performance in January, the results weren’t all that great. The big drugmaker posted earnings per share that came in $0.03 below what Wall Street expected.
Pfizer provides its first-quarter 2017 update on May 2. Will the company surprise investors in a positive way this time around? Here are three key things to watch with Pfizer’s results.